BIPOLAR DISORDER IN ADULTS
Author(s) -
Jaya Yadav,
Satish Kumar Sharma,
Lalit Kumar Singh,
Tanuja Singh,
Deepa Chauhan
Publication year - 2013
Publication title -
international research journal of pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2230-8407
DOI - 10.7897/2230-8407.04608
Subject(s) - bipolar disorder , psychology , medicine , psychiatry , lithium (medication)
Bipolar disorder is a chronic illness, which may require life-long treatment. Patients will spend 3-5 times more days in the depressed episode then in the manic phase. Due to this variability in episodes, polypharmacy is used quite frequently in practice, though the evidence to do this remains quite limited. Many positive and negative outcomes can occur from this practice. Bipolar disorder is the 6th leading cause of disability in the developed world among those between the ages 15 and 44 years age groups. Serotonin is one of the neurotransmitter in the brain, and one of that strongly affects the person mood. Clozapine (clozaril), olanzapine (zyperexa), risperidone (Risperdal), and ziprasidone (zeldox) and the clozapine may be helpful as mood stabilizer for people who do not respond to lithium and anticonvulsant
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom